Emergency useThe company’s vaccine, dubbed CoronaVac, is made with the coronavirus rendered inactive so that the pathogen cannot cause infection but can train the human immune system to recognize and respond to real infections.State-owned China National Biotec Group is currently testing two coronavirus vaccines in countries across the Middle East and South America, while Tianjin-based CanSino Biologics Inc., or CNBG, is trialling a shot co-developed with the Chinese military in Russia and Pakistan.Both Sinovac and CNBG’s shots have been approved for emergency use for doctors, nurses and other front-line workers under China’s vaccine law, while CanSino’s shot received approval for use within the Chinese military.Click here to read the Mint.